Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.12
-0.34
(-2.97%)
USD |
NASDAQ |
Sep 04, 16:00
10.92
-0.20
(-1.80%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Total Assets (Quarterly) : 126.99M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 126.99M |
| March 31, 2026 | 144.48M |
| December 31, 2025 | 168.20M |
| September 30, 2025 | 109.51M |
| June 30, 2025 | 125.08M |
| March 31, 2025 | 139.93M |
| December 31, 2024 | 155.88M |
| September 30, 2024 | 164.17M |
| June 30, 2024 | 151.98M |
| March 31, 2024 | 125.74M |
| December 31, 2023 | 28.27M |
| September 30, 2023 | 36.28M |
| June 30, 2023 | 43.72M |
| March 31, 2023 | 51.65M |
| December 31, 2022 | 66.31M |
| September 30, 2022 | 73.83M |
| June 30, 2022 | 82.07M |
| March 31, 2022 | 95.68M |
| December 31, 2021 | 107.73M |
| September 30, 2021 | 119.57M |
| June 30, 2021 | 120.61M |
| March 31, 2021 | 140.14M |
| December 31, 2020 | 102.29M |
| September 30, 2020 | 95.84M |
| June 30, 2020 | 98.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 65.20M |
| December 31, 2019 | 49.14M |
| September 30, 2019 | 68.13M |
| June 30, 2019 | 84.12M |
| March 31, 2019 | 101.39M |
| December 31, 2018 | 46.99M |
| September 30, 2018 | 61.18M |
| June 30, 2018 | 70.29M |
| March 31, 2018 | 77.14M |
| December 31, 2017 | 66.98M |
| September 30, 2017 | 38.42M |
| June 30, 2017 | 44.56M |
| March 31, 2017 | 50.61M |
| December 31, 2016 | 17.89M |
| September 30, 2016 | 19.76M |
| June 30, 2016 | 22.63M |
| March 31, 2016 | 10.50M |
| December 31, 2015 | 12.88M |
| September 30, 2015 | 13.33M |
| June 30, 2015 | 9.565M |
| March 31, 2015 | 5.246M |
| December 31, 2014 | 6.601M |
| September 30, 2014 | 7.630M |
| June 30, 2014 | 8.535M |
| March 31, 2014 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.75M |
| Shareholders Equity (Quarterly) | 102.24M |
| Debt to Equity Ratio | 0.0417 |
| Current Ratio | 5.714 |
| Net Debt Paydown Yield | -0.16% |